NATURECEUTICALS PIONEERING - THE WORLD FIRST PRESCRIPTION BOTANICAL DRUG FOR CANCER THERAPY BY TARGETING A KEY PHYSIOLOGICAL PROCESS KNOWN AS ANGIOGENESIS WHICH PLACE CRUCIAL ROLE IN ALL TUMOR GROWTH AND DEVELOPMENT.
NatureCeuticals is a pharmaceutical company that specialises in prescription base botanical drugs.
NatureCeuticals is established based on research collaboration between top Australian and Malaysian universities. We aspire to transform medicinal herbs into main stream pharmaceuticals that are safe and effective. We go to great lengths to achieve what is thought to be impossible for herbs by introducing ground breaking technologies that helps to catapult herbs into pharmaceuticals.
Our proprietary state-of-the-art manufacturing and formulation technologies help to improve the potency of our herbal products. These help to increase the amount of vital plant nutrients and enhance their absorption making our herbal products far more effective than their natural form.
We conduct clinical and preclinical studies on our products to validate their safety and effectiveness. Our commitment to continuously improve herbal pharmaceuticals has led us to establish our very own not-for-profit research institute to advance our scientific endeavour . We also support various university research projects to help to deepen our knowledge and understanding in modern herbal medicine.
Nuvastatic has obtained approval to
comments phase 2 clinical study for colon
cancer. This study is currently underway
and expected to be completed by 3rd
Phase 2 clinical studies on breast
cancer patients is currently ongoing
on Nuvastatic. This study is
expected to be completed before
end of 2020.
Nuvastatic has obtained Approval for Phase
1b/2a for Diabetic Retinopathy. Currently
more than 100 patients are being recruited
for this study.
Nuvastatic has obtained approval by Malaysian Drug regulatory authority as complementary medicine.